COVID-19 patients treated with convalescent plasma

LOMA LINDA – (INT) - Loma Linda University Health is currently treating eligible patients battling severe novel coronavirus (COVID-19) with convalescent plasma in hopes of boosting their ability to fight the virus.

The patients are treated while in the hospital through a transfusion of serum containing virus-neutralizing antibodies, which were removed from a recovered individual’s donated blood.

Tait Stevens, MD, president of medical staff at Loma Linda University Medical Center, said some evidence shows that patients currently suffering from COVID-19 recover better if they receive plasma from those who have previously recovered. Stevens cited a study published in April that showed encouraging results from 10 severe adult cases who received the convalescent plasma, maintained or increased the antibodies and went on to recover. “This study showed promising results, and we want to do everything we can to continue this fight against COVID-19,” Stevens said.

Rohith Mohan, MD, a second-year pediatric resident at Loma Linda University Children’s Hospital, began having symptoms in mid-March. He recovered within approximately 10 days but continued to test positive for the virus for 40 days. Mohan donated blood at a LifeStream donation center on May 16th. His antibody-filled plasma could now potentially provide treatment for up to four patients currently battling the disease he overcame.